Biopharmaceutical MannKind, which has its headquarters in Westlake Village, is positioning itself as a med-tech platform. (Courtesy photo) Despite delivering rising sales, Westlake Village-based MannKind saw shares drop nearly 20% in the week after its latest announcement, after the company failed to translate higher revenue into profit. Announced after the markets closed on Feb. 26,…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
